Registry update — unassessed
Low Load Blood Flow Restriction Resistance Training in Colorectal Cancer Related Sarcopenia
Trial registry update: RECRUITING. No results reported in the supplied registry record.
RCTMinor significance
What this changes
The finding has not established an approved change to our evidence assessment.
Source date: Oct 21, 2026 · Discovered: Oct 14, 2026 · Assessed: — · Research update
What it does not prove
- The abstract does not report any findings or outcome data, so no efficacy claims can be evaluated from this material.
- Sample size is not reported, preventing assessment of statistical power or generalizability.
- Without results, it cannot be determined whether observed effects (if any) are clinically meaningful or specific to blood flow restriction versus other training modalities.
Extracted from supplied source material; model confidence is not a measured probability of correctness.
Study details
- Design
- Rct
- Sample size
- —
- Duration
- —
- Population
- colorectal cancer survivors with probable sarcopenia
- Primary outcome
- muscle strength
- Effect size
- —
- Significance
- Not reported
- Journal
- Ahmed Adel Ahmed Elsayed Ali Radwan
- Published
- Oct 21, 2026
Sources
Primary source
- Ahmed Adel Ahmed Elsayed Ali Radwan ↗Clinical trial
Recorded source passages
Abstract or registry material supplied for assessment; source version 2. This is not a claim of full-text review.
To investigate the effects of low-load resistance training combined with blood flow restriction on muscle strength, functional performance, and cancer-related fatigue in colorectal cancer survivors with probable sarcopenia.
It is hypothesized that low-load blood flow restriction resistance training will lead to significant improvements in muscle strength and functional performance and a significant reduction in cancer-related fatigue in colorectal cancer survivors with probable sarcopenia.
Does low-load blood flow restriction resistance training lead to significant improvements in muscle strength and functional performance and a significant reduction in cancer-related fatigue in colorectal cancer survivors with probable sarcopenia?
Source versions
Assessment history
Discussion (0)
One thread per scientific event, no matter how many outlets covered it.
Sign in to join the discussion.
No comments yet
Be the first to weigh in on this evidence.